The Ovarian Cancer National Alliance is partnering with the Society of Gynecologic Oncology (SGO) on a first-of-its-kind survey for women with ovarian cancer. Your input will help the Alliance and SGO better understand the patient perspective on outcomes from clinical research and could help shape future research. We urge all ovarian cancer survivors to click here to complete the short survey. We want to know which endpoints are meaningful to you, and what impact various side effects have on your quality of life. This information could influence how ovarian cancer drugs are evaluated, approved and covered in the future.